Egalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.

Wayne, US
115 (est)
Egalet was founded in 1995 and is headquartered in Wayne, US

Egalet Locations

Wayne, US

Egalet Metrics

Egalet Summary

Market capitalization

$129 M

Closing share price

Egalet's current market capitalization is $129 M.

Egalet Market Value History

Egalet Online Presence

Egalet Company Life

You may also be interested in